Vertex Pharmaceuticals Incorporated beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $4.15 | $4.20 | +1.2% | Beat |
| Q12026 FY2026 | $3.69 | $3.95 | +7.0% | Beat |
| Q42025 FY2025 | $4.41 | — | — | Miss |
Back to VRTX overview · VRTX holders · VRTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.